| Jeanne E Poole, MD | |
|
1959 Ne Pacific St, Seattle, WA 98195-0001 | |
| (206) 598-4300 | |
| Not Available |
| Full Name | Jeanne E Poole |
|---|---|
| Gender | Female |
| Speciality | Cardiac Electrophysiology |
| Experience | 44 Years |
| Location | 1959 Ne Pacific St, Seattle, Washington |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073637732 | NPI | - | NPPES |
| 8568800 | Medicaid | WA |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Washington Medical Ctr | Seattle, WA | Hospital |
| Harborview Medical Center | Seattle, WA | Hospital |
| Valley Medical Center | Renton, WA | Hospital |
| Evergreenhealth Medical Center | Kirkland, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Association Of University Physicians | 0446162697 | 3009 |
News Archive
A research team at the Ludwig Institute and Uppsala University has discovered an entirely new signal path for a growth factor that is of crucial importance for the survival and growth of cancer cells.
Clarient, Inc., a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced the commercial launch of a new lung cancer test, Clarient Insight® Dx Pulmotype® Test, that helps physicians classify specific types of lung cancer to identify which therapies may be most effective.
In the U.S., more than 180,000 women are diagnosed with invasive breast cancer each year. Many of these women will undergo mastectomy surgery that will result in disfiguring scars because they are unaware of the availability of skin-sparing mastectomies and did not ask their surgeons about this treatment option. Skin-sparing mastectomy is a surgical technique to remove cancerous breast tissue by using the same minimal and judiciously placed incisions used by plastic surgeons for elective breast surgery.
CDEX Inc. extends its congratulations to Dr. Jim Stevenson and members of his staff at the CS Mott Children's Hospital of the University of Michigan Health System, among the best in the nation, recipients of the 2009 ASHP Literature Award for Pharmacy Practice Research.
Celera Corporation, a health care company focused on genetics, and Medical Therapies Limited (ASX:MTY), a biotechnology company developing midkine-related diagnostic and therapeutic products, have entered into an exclusive license agreement for the use of MTY's midkine patent portfolio for the development of novel lung cancer diagnostics.
› Verified 9 days ago
| Entity Name | The Association Of University Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023041159 PECOS PAC ID: 0446162697 Enrollment ID: O20031105000244 |
News Archive
A research team at the Ludwig Institute and Uppsala University has discovered an entirely new signal path for a growth factor that is of crucial importance for the survival and growth of cancer cells.
Clarient, Inc., a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced the commercial launch of a new lung cancer test, Clarient Insight® Dx Pulmotype® Test, that helps physicians classify specific types of lung cancer to identify which therapies may be most effective.
In the U.S., more than 180,000 women are diagnosed with invasive breast cancer each year. Many of these women will undergo mastectomy surgery that will result in disfiguring scars because they are unaware of the availability of skin-sparing mastectomies and did not ask their surgeons about this treatment option. Skin-sparing mastectomy is a surgical technique to remove cancerous breast tissue by using the same minimal and judiciously placed incisions used by plastic surgeons for elective breast surgery.
CDEX Inc. extends its congratulations to Dr. Jim Stevenson and members of his staff at the CS Mott Children's Hospital of the University of Michigan Health System, among the best in the nation, recipients of the 2009 ASHP Literature Award for Pharmacy Practice Research.
Celera Corporation, a health care company focused on genetics, and Medical Therapies Limited (ASX:MTY), a biotechnology company developing midkine-related diagnostic and therapeutic products, have entered into an exclusive license agreement for the use of MTY's midkine patent portfolio for the development of novel lung cancer diagnostics.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jeanne E Poole, MD Po Box 50095, Seattle, WA 98145-5095 Ph: (206) 543-6420 | Jeanne E Poole, MD 1959 Ne Pacific St, Seattle, WA 98195-0001 Ph: (206) 598-4300 |
News Archive
A research team at the Ludwig Institute and Uppsala University has discovered an entirely new signal path for a growth factor that is of crucial importance for the survival and growth of cancer cells.
Clarient, Inc., a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced the commercial launch of a new lung cancer test, Clarient Insight® Dx Pulmotype® Test, that helps physicians classify specific types of lung cancer to identify which therapies may be most effective.
In the U.S., more than 180,000 women are diagnosed with invasive breast cancer each year. Many of these women will undergo mastectomy surgery that will result in disfiguring scars because they are unaware of the availability of skin-sparing mastectomies and did not ask their surgeons about this treatment option. Skin-sparing mastectomy is a surgical technique to remove cancerous breast tissue by using the same minimal and judiciously placed incisions used by plastic surgeons for elective breast surgery.
CDEX Inc. extends its congratulations to Dr. Jim Stevenson and members of his staff at the CS Mott Children's Hospital of the University of Michigan Health System, among the best in the nation, recipients of the 2009 ASHP Literature Award for Pharmacy Practice Research.
Celera Corporation, a health care company focused on genetics, and Medical Therapies Limited (ASX:MTY), a biotechnology company developing midkine-related diagnostic and therapeutic products, have entered into an exclusive license agreement for the use of MTY's midkine patent portfolio for the development of novel lung cancer diagnostics.
› Verified 9 days ago
Sandhya Ramanathan Panch, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 825 Eastlake Ave E, Seattle, WA 98109 Phone: 206-520-5000 | |
Stephen A Lopez, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 925 Seneca St, Seattle, WA 98101 Phone: 206-341-0860 | |
Dr. Susan Hunt, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: Uwmc Department Of Medicine, Box 356429, Seattle, WA 98195 Phone: 206-221-7993 Fax: 206-221-8732 | |
Timothy William Menza, MD, PHD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 325 9th Ave, Seattle, WA 98104 Phone: 206-520-5000 | |
Dr. Vinay Gupta, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1100 9th Ave, Seattle, WA 98101 Phone: 206-223-6980 Fax: 206-223-6982 | |
Dr. Maria Ann Corcorran, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1550 N 115th St, Seattle, WA 98133 Phone: 206-520-5000 | |
Vyshak Alva Venur, M.D Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 825 Eastlake Ave E, Seattle, WA 98109 Phone: 206-520-5700 |